All Companies
Ticker OBX
Foundation Sweep — share basis uncertain
You reached the page — here's exactly what OBX is, and why it's out of scope for now.
What this ticker is
OBX
Obsidian Therapeutics Inc.
NASDAQ
Healthcare
Biotechnology
United States
Mkt cap $1.1B
Obsidian Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on engineered cell and gene therapies for cancer, with an emphasis on solid tumors. The company develops tumor-infiltrating lymphocyte (TIL) therapies built on its proprietary cytoDRiVE platform, which is designed to control protein function using FDA-approved small-molecule dr…
Why we can't analyze it yet
F5 · Thin bench — a small/young filer with no cover-page count; nothing contradicts the divisor · divisor 61,772,876 — 1 witness(es) agree [tape] — need 2, so the basis is unverified rather than wrong
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
share_basis_unverified